Erectile Dysfunction Flashcards

1
Q

Define erectile dysfunction (ED)

A

The persistent/recurrent inability to achieve or maintain an erection of sufficient rigidity to permit satisfactory sexual activity for at least 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define sexual dysfunction

A

More encompassing

May include ED, +/or diminished libido, premature or delayed ejaculation, orgasm, or priapism

  • broad terminology (encompasses erectile dysfunction)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does an erection occur overall?

A

Complex interaction between the vascular, hormonal, neurological, and psychological systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the physiology of an erection

A

When stimulated, acetylcholine produces an erection through multiple pathways which ultimately increase the levels of cGMP, cAMP and nitric oxide.

This results in smooth muscle relaxation which increases arterial blood flow, allowing the corpora to fill with blood.

Flacid State: Flow of blood into and out of the corpora is equal

Erect State - Flow in of blood > FLow out of the corproa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does erectile dysfunction occur?

A

Any abnormality in the vascular, hormonal, neurologic, or psychogenic system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the prevalence of the causes of erectile dysfunction?

A

~ 80% of ED cases related to organic disease
Vascular
hormonal
or neurologic causes

<10% of ED cases are due to psychogenic factors

up to 25% of ED cases are medication-induced

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the impact of ED. What should a pharmacist investigate if new onset ED?

A

Can be distressing for the person and their partner(s)
80% of the time – due to disease causes

There are many drug causes

– Concern when New onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the risk factors for erectile dysfunction?

A

Age
Lifestyle: Tobacco, Obesity, Sedentary
Medical Conditions e.g. CVD, Diabetes
Medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the epidemiology of erectile dysfunction

A

Incidence is low in men <40yo, increases with age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the vascular causes of erectile dysfunction?

A

Disease states that compromise vascular flow to the corpora cavernosum can cause ED

The most common cause(s) of ED
Associated medical conditions:
Diabetes
Atherosclerosis
Hypertension
Renal Disease
Liver Disease
Excessive cigarette smoking
Radiation (causing vascular damage)

Impaired blood flow to the corpora and can be associated with numerous medical conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the relationship between ED and CAD

A

Blood vessels in penis are small so may be showing signs of atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the relationship between ED, PDE5i’s and diabetes

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the neurological relationship of ED

A

Sexual arousal causes nerve impulses to travel from the brain via the spinal cord to the genital region

Conditions that impair nerve conduction to the brain:
Spinal cord injury
Stroke
Pelvic trauma, prostate surgery

Conditions that impair nerve conduction to the penile vasculature:
Parkinsons, Alzheimer’s, multiple sclerosis, epilepsy
Diabetic neuropathy, alcoholic neuropathy

Impaired nerve function in the brain and in the penis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the hormonal causes of ED

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the psychogenic causes of ED and the treatment

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When is psychogenic causes of ED more common? Response?

A

More common in younger indivdiuals
Response here is often better – No dmage to te parts needed to cause an erection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the causees of drug induced ED and the mechanisms for which it occurs?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Diagnosis of ED depends on evelauation of

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Goals of TX ED

20
Q

Non-RX TX ED and benefit

A

Can be managed; often cannot be cured
Counselling if psychological factors

21
Q

1st LIne tegrapy for ED

22
Q

Describe the MOA of PDE5 Inhibitors. Is this all that is required for an erection?

A

Type-5 enzyme is more common in the corpora

Sexual stimulation is still required to maintain an erection

23
Q

Effeicacy of PDE5 Inhibitors and Trial

A

Similar for all 3: success rates from 60-70%

Efficacy is improved with education

1st dose can be efficacious, but can see improved success with successive doses

Should be tried 6 to 8 times before judging their success

Non-response in 4-6 tries under optimal conditions at max dose

Effect is dose related (80% of effect at low dose; further 20% at high dose)

Failure with one PDE5I does not rule out a trial of another

24
Q

Comapre the PDE5 Inhibitors

25
Q

Sildenafil Education

A

Takes 60 minutes to peak

Lasts for only about 4 hours (up to 12)

High fat meal delays the onset

26
Q

Vardenafil education

A

Takes 60 minutes to peak
 Lasts for only about 4 hours
 High fat meal decreases absorption
 No renal dose adjustment
 ODT tablet available

27
Q

TAdalafil Education

A

Takes 120 minutes to peak
 Lasts up to 36 hours (“weekender drug”)
 Food has no impact
 Can daily dose or use prn

28
Q

Metabolism of PDE% Inhibitors

A

All metabolized via CYP 3A4 (major pathway)
Sildenafil & vardenafil: also 2C9 (minor pathway)

29
Q

Drug Inetractions PDE5 Inhibiutors

A

Nitrates –> severe hypotension! (contraindicated!)

The vasodilator actions of nitrates (po, sl, transdermal) are profoundly amplified with concomitant use of PDE5 Inhibitors and this could be fatal

CYP 3A4 inducers and inhibitors (use with caution)
Examples: Ketoconazole, protease inhibitors, erythromycin, grapefruit juice, etc.

Non-selective α1-blockers (particularly terazosin/doxazosin): may experience further hypotensive effects–recommended to space dosing by 4-6hrs if used these together

Antihypertensives?? – OK as long as BP is fine

30
Q

Nitrates and PDE5 Waiting

A

Reality – Long acting nitro patch – cannot not use them at all

PRN nitro spray – Can use PDE5 inhibitors – Cannot use nitro spray after
(Tadalafil 48 h, sildenafil/vardenafil 24 h)

Experience chest pain that does not go away at rest for 5 mins – Hospital

31
Q

Caution of PDE5

A

Sexual activity increases the chances of experiencing ischemic events and myocardial infarction

Avoid use in those at high risk of CV events (e.g. unstable angina, class IV HF, recent stroke/MI, high risk arrhytmias, uncontrolled HTN)

32
Q

Adverse EFfects PDE inhibitors

A

Overall well-tolerated

Most common: headache (14%), flushing (4-12%), dyspepsia (4-7%), dizziness, rash, rhinitis/nasal congestion (4%)

Others:

Back and muscle pain (inhibition of PDE11 in skeletal muscle): tadalafil (2-5%)

Hypotension (inhibition of PDE1): sildenafil and vardenafil > tadalafil
8-10mmHG SBP and 5-8 DBP within an hour – lasts a few hours

Color visual changes (inhibition of PDE6 in the retina):
Blurred vision, ↑ light sensitivity
Loss of blue – green differentiation (up to 2-3%; dose-related; Sildenafil > vardenafil > tadalafil)

33
Q

Seerious Adverse EFfects

A

Serious but rare:
Sudden unilateral hearing loss: post-marketing reports
NAION (nonarteritic anterior ischemic optic neuropathy)- sudden, unilateral, vision loss
Post-marketing reports (<0.01%)
Those at risk of NAION should be evaluated by an eye doc first

QT prolongation with vardenafil
Priapism
Chest pain

34
Q

Alprostadil MOA

A

Stimulates ↑’d production of cAMP and causes smooth muscle relaxation of tissues in the corpora & restricts venous outflow

35
Q

Alprostadil Products

A

Intracavernosal injection: Caverject®

Intraurethral insert: MUSE®

36
Q

Alprostadil Dose, Onset and Efficcay of Options

37
Q

Alprostadil Admin and Caution

A

Inject 10-30min pre-sex
If erection lasts >1hr, decrease dose
If erection lasts >4hrs, seek help

38
Q

Alprostadil Adverse Effects. Caution with medictaions?

39
Q

C.I. Alprostadil

A

C.I in those with a predisposition to priapism – Had it before, sickle cell disease,

40
Q

Other agents for ED. Are they common?

A

o Papaverine use limited by adverse effects
o Phentolamine use limited by adverse effects

41
Q

Otehr therapies for ED

A

Surgery - can be an option: effective but Risks

Testosterone should not be sued for erecetile dysfuntion on its own – can be sued in patients with low testosterone and erectile dysfunction

42
Q

Non-Rx Deveices for ED Advatages and disadvatages?

43
Q

Female Sexual Dysfucntion Prevalence

A

~ 40% of women had sexual concerns
Low desire
Orgasmic disorder
Sexual pain
May be due to physical (medical conditions and medications), hormonal, or psychological conditions

44
Q

Female Sexual Dysfucntion TX

A

treatment options are much more limited

PDE5i’s: not effective, could maybe possible ↓ SSRI AEs

Topical estrogen
May enhance lubrication, decrease dyspareunia

Testosterone: controversial

45
Q

Female Sexual Dysfucntion TX Med